ProgenyHealth Secures Growth Investment from Cressey & Co and Sunstone Partners

Deal News | May 20, 2025 | Cressey & Co LP

ProgenyHealth, a key player in maternity and NICU care management, has secured a major growth investment from Cressey & Company and its existing backer, Sunstone Partners. This injection of funds is intended to fuel the company's service expansion across the U.S., enhancing maternal and infant health outcomes. Sunstone Partners initially invested in ProgenyHealth in 2017, leading to substantial business growth and the management of 140,000 NICU births. Both investment firms aim to further elevate the company's growth trajectory. ProgenyHealth will benefit not only from financial support but also from Cressey's healthcare expertise and resources, marking a strategic move for the company and the broader healthcare sector.

Sectors

  • Healthcare Services
  • Private Equity

Geography

  • United States – ProgenyHealth operates nationally within the U.S., and the investment aims to expand services across the country.

Industry

  • Healthcare Services – The article focuses on ProgenyHealth, which provides healthcare services in maternal and NICU care management.
  • Private Equity – The article discusses investment activities involving private equity firms Cressey & Company and Sunstone Partners.

Financials

  • Not specified – Specific financial terms of the investment were not disclosed in the article.

Participants

NameRoleTypeDescription
ProgenyHealth, LLCTarget CompanyCompanyA leader in maternity and NICU care management.
Cressey & Co LPInvestorCompanyA private equity firm focused on healthcare services.
Sunstone PartnersInvestorCompanyA growth-oriented private equity firm and existing investor in ProgenyHealth.
Susan TorroellaCEOPersonChief Executive Officer of ProgenyHealth.
Ellen Stang, MDFounderPersonFounder of ProgenyHealth.
Steven DildinePartner at CresseyPersonPartner at Cressey & Company.
Arneek MultaniCo-Founder and Managing PartnerPersonCo-Founder and Managing Partner at Sunstone Partners.
TripleTree and Goodwin ProcterAdvisorsCompanyAdvised ProgenyHealth and Sunstone Partners on the deal.
Baird and Ropes & GrayAdvisorsCompanyAdvised Cressey & Company on the deal.